Insecticide resistance across the Northeast and Mid-Atlantic United States: results from 6 years of monitoring (2019–2024)

In 2019, the Northeast Regional Center for Excellence in Vector-Borne Diseases (NEVBD) initiated a unique region-wide insecticide resistance monitoring program covering the Northeast and Mid-Atlantic United States regions. NEVBD evaluated 2 key mosquito vectors, Aedes albopictus Skuse [Diptera: Culicidae] and Culex pipiens L. [Diptera: Culicidae], for resistance to insecticides deployed against larval and adult mosquitoes. Additionally, Culex restuans Theobald [Diptera: Culicidae] mortality was assessed. Insecticide use surveys provided insights into the region's resistance monitoring capacity and insecticide usage. In response to these surveys, NEVBD developed susceptibility curves, diagnostic doses, and larval bioassays for regionally important larvicides. Adulticide resistance was assessed using CDC bottle bioassays. A total of 42 agencies submitted mosquitoes for testing, including Cx. pipiens (79%), Ae. albopictus (10%) and Cx. restuans (10%). Culex pipiens populations with moderate to high pyrethroid resistance were identified in several locations, along with emerging resistance to organophosphates in Virginia. Additionally, Cx. pipiens resistance to the larvicide methoprene was widespread, while no resistance to Bacillus thuringiensis israelensis (Bti) Berliner or Lysinibacillus sphaericus Meyer and Neide was detected. All Ae. albopictus submitted for larvicide testing were susceptible to Bti; but displayed low-level methoprene resistance. To empower regional partners to make informed vector control decisions, NEVBD's resistance data were made publicly available. In addition, organized training sessions and consultations were provided on resistance monitoring practices. Our results confirm the presence of multi-year region-wide insecticide resistance data for medically relevant mosquitoes across the Northeast and Mid-Atlantic states, highlighting the need for coordinated resistance monitoring and training to successfully protect public health.

Authors

Institutions

Publication Details

Journal
Journal of Medical Entomology
Published
2025-11-26
DOI
https://doi.org/10.1093/jme/tjaf171
Citations
1
Primary Topic
Mosquito-borne diseases and control
Type
article
Field-Weighted Citation Impact
1.88
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Insecticide resistance across the Northeast and Mid-Atlantic United States: results from 6 years of monitoring (2019–2024)

Elisabeth Martin, Áine Lehane, Laura C. Harrington, James C. Burtis et al.
1 citations
Journal of Medical Entomology
Mosquito-borne diseases and control
1.88
article

Insecticide resistance across the Northeast and Mid-Atlantic United States: results from 6 years of monitoring (2019–2024)

Elisabeth Martin, Áine Lehane, Laura C. Harrington, James C. Burtis, Lindsay Baxter, Veronica Fell, Amanda Peh, Jake Angelico
article en
1 citations

Abstract

In 2019, the Northeast Regional Center for Excellence in Vector-Borne Diseases (NEVBD) initiated a unique region-wide insecticide resistance monitoring program covering the Northeast and Mid-Atlantic United States regions. NEVBD evaluated 2 key mosquito vectors, Aedes albopictus Skuse [Diptera: Culicidae] and Culex pipiens L. [Diptera: Culicidae], for resistance to insecticides deployed against larval and adult mosquitoes. Additionally, Culex restuans Theobald [Diptera: Culicidae] mortality was assessed. Insecticide use surveys provided insights into the region's resistance monitoring capacity and insecticide usage. In response to these surveys, NEVBD developed susceptibility curves, diagnostic doses, and larval bioassays for regionally important larvicides. Adulticide resistance was assessed using CDC bottle bioassays. A total of 42 agencies submitted mosquitoes for testing, including Cx. pipiens (79%), Ae. albopictus (10%) and Cx. restuans (10%). Culex pipiens populations with moderate to high pyrethroid resistance were identified in several locations, along with emerging resistance to organophosphates in Virginia. Additionally, Cx. pipiens resistance to the larvicide methoprene was widespread, while no resistance to Bacillus thuringiensis israelensis (Bti) Berliner or Lysinibacillus sphaericus Meyer and Neide was detected. All Ae. albopictus submitted for larvicide testing were susceptible to Bti; but displayed low-level methoprene resistance. To empower regional partners to make informed vector control decisions, NEVBD's resistance data were made publicly available. In addition, organized training sessions and consultations were provided on resistance monitoring practices. Our results confirm the presence of multi-year region-wide insecticide resistance data for medically relevant mosquitoes across the Northeast and Mid-Atlantic states, highlighting the need for coordinated resistance monitoring and training to successfully protect public health.

Journal of Medical EntomologyVol. 63(1)
Cornell University (US), National Center for Emerging and Zoonotic Infectious Diseases (US)
Openalex Percentile: Top 10%
Mosquito-borne diseases and control
1.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.